U.S. flag

An official website of the United States government

NM_005896.4(IDH1):c.395G>A (p.Arg132His) AND Astrocytoma

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jul 14, 2015
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000442517.2

Allele description [Variation Report for NM_005896.4(IDH1):c.395G>A (p.Arg132His)]

NM_005896.4(IDH1):c.395G>A (p.Arg132His)

Gene:
IDH1:isocitrate dehydrogenase (NADP(+)) 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q34
Genomic location:
Preferred name:
NM_005896.4(IDH1):c.395G>A (p.Arg132His)
HGVS:
  • NC_000002.12:g.208248388C>T
  • NG_023319.2:g.22687G>A
  • NM_001282386.1:c.395G>A
  • NM_001282387.1:c.395G>A
  • NM_005896.4:c.395G>AMANE SELECT
  • NP_001269315.1:p.Arg132His
  • NP_001269316.1:p.Arg132His
  • NP_005887.2:p.Arg132His
  • LRG_610t2:c.395G>A
  • LRG_610t3:c.395G>A
  • LRG_610:g.22687G>A
  • LRG_610p2:p.Arg132His
  • LRG_610p3:p.Arg132His
  • NC_000002.11:g.209113112C>T
  • NM_005896.3:c.395G>A
  • O75874:p.Arg132His
Protein change:
R132H; ARG132HIS
Links:
UniProtKB: O75874#VAR_055455; OMIM: 147700.0001; dbSNP: rs121913500
NCBI 1000 Genomes Browser:
rs121913500
Molecular consequence:
  • NM_001282386.1:c.395G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282387.1:c.395G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005896.4:c.395G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Astrocytoma
Synonyms:
Astrocytoma (excluding glioblastoma)
Identifiers:
MONDO: MONDO:0019781; MeSH: D001254; MedGen: C0004114; Human Phenotype Ontology: HP:0009592

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000503813Database of Curated Mutations (DoCM)
no assertion criteria provided
Likely pathogenic
(Jul 14, 2015)
somaticliterature only

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedsomaticyesnot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Prospective enterprise-level molecular genotyping of a cohort of cancer patients.

MacConaill LE, Garcia E, Shivdasani P, Ducar M, Adusumilli R, Breneiser M, Byrne M, Chung L, Conneely J, Crosby L, Garraway LA, Gong X, Hahn WC, Hatton C, Kantoff PW, Kluk M, Kuo F, Jia Y, Joshi R, Longtine J, Manning A, Palescandolo E, et al.

J Mol Diagn. 2014 Nov;16(6):660-72. doi: 10.1016/j.jmoldx.2014.06.004. Epub 2014 Aug 23.

PubMed [citation]
PMID:
25157968
PMCID:
PMC4210463

A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation.

Kato Y, Jin G, Kuan CT, McLendon RE, Yan H, Bigner DD.

Biochem Biophys Res Commun. 2009 Dec 18;390(3):547-51. doi: 10.1016/j.bbrc.2009.10.001. Epub 2009 Oct 7.

PubMed [citation]
PMID:
19818334
PMCID:
PMC2788025
See all PubMed Citations (3)

Details of each submission

From Database of Curated Mutations (DoCM), SCV000503813.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (3)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024